1. Volume 4, Issue 5, Pages 443-445 (June 2018)
Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib 
Sa Rang Kim, BSc, Alexandra Charos, MD, PhD, William Damsky, MD, PhD, Peter Heald, MD, Michael Girardi, MD, Brett A. King, MD, PhD 
JAAD Case Reports 
Volume 4, Issue 5, Pages (June 2018)
DOI: /j.jdcr
Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
A, Before treatment with tofacitinib, patient with GDM was unable to appose her hands (positive prayer sign). B, After 8 months of treatment with tofacitinib, she could fully extend her digits.
JAAD Case Reports 2018 4, DOI: ( /j.jdcr )
Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
A, Before treatment with tofacitinib, pseudocellulite appearance and linear depressions (groove sign) of the right arm were prominent in patient with EF. B, After 19 months of treatment with tofacitinib and methotrexate, pseudocellulite appearance and linear depressions are resolved.
JAAD Case Reports 2018 4, DOI: ( /j.jdcr )
Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions